Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07655648

Dual-tracer PET Radiomics for Prostate Cancer Stratification

Sponsor: Xiangya Hospital of Central South University

View on ClinicalTrials.gov

Summary

This single-center retrospective study aims to develop an interpretable radiomics model based on dual-tracer PET/CT to preoperatively predict the postoperative pathological Gleason grade group in treatment-naïve prostate cancer patients. A machine learning-based three-class prediction model will be constructed and interpreted using SHAP. Its performance will be compared with systematic biopsy results, assessing grading accuracy and prognostic value for biochemical recurrence-free survival.

Official title: Dual-tracer PET/CT Interpretable Radiomics for Pathological Classification and Prognostic Stratification of Prostate Cancer

Key Details

Gender

MALE

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2020-01-01

Completion Date

2026-05-01

Last Updated

2026-06-18

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

PET/CT with Gallium-68 labeled PSMA and RM26

Retrospective analysis of pre-prostatectomy dual-tracer PET/CT (⁶⁸Ga-PSMA and ⁶⁸Ga-RM26) imaging data.

Locations (1)

Department of Nuclear Medicine, Xiangya Hospital, Central South University

Changsha, Hunan, China